Oncology Institute Inc’s filing revealed that its Director Pacala Mark L unloaded Company’s shares for reported $0.2 million on Nov 18 ’25. In the deal valued at $4.00 per share,50,000 shares were sold. As a result of this transaction, Pacala Mark L now holds 174,971 shares worth roughly $0.55 million.
Then, MARK PACALA bought 50,000 shares, generating $200,000 in total proceeds.
Before that, M33 Growth I L.P. sold 6,018,168 shares. Oncology Institute Inc shares valued at $18,596,139 were divested by the Director at a price of $3.09 per share. As a result of the transaction, M33 Growth I L.P. now holds 7,932,389 shares, worth roughly $24.91 million.
Needham initiated its Oncology Institute Inc [TOI] rating to a Buy in a research note published on November 25, 2025; the price target was $5. A number of analysts have revised their coverage, including Noble Capital Markets’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. B. Riley Securities began covering TOI with “Buy” recommendation on July 16, 2025. BTIG Research started covering the stock on May 15, 2025. It rated TOI as “a Buy”.
Price Performance Review of TOI
On Friday, Oncology Institute Inc [NASDAQ:TOI] saw its stock jump 0.64% to $3.14. Over the last five days, the stock has lost -3.09%. Oncology Institute Inc shares have risen nearly 1972.61% since the year began. Nevertheless, the stocks have risen 916.18% over the past one year. While a 52-week high of $4.88 was reached on 10/24/25, a 52-week low of $0.15 was recorded on 01/10/25.
Levels Of Support And Resistance For TOI Stock
The 24-hour chart illustrates a support level at 3.07, which if violated will result in even more drops to 3.00. On the upside, there is a resistance level at 3.20. A further resistance level may holdings at 3.26.
How much short interest is there in Oncology Institute Inc?
A steep rise in short interest was recorded in Oncology Institute Inc stocks on 2025-11-14, dropping by -1.38 million shares to a total of 4.45 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 5.83 million shares. There was a decline of -31.05%, which implies that there is a negative sentiment for the stock.
